BeStock  
Stocks › BRVE

Braveheart Bio BRVE

US equityMarket cap rank #2809Biotechnology
$21.35 +$0.08 (+0.38%)
Market closed · Oct 6, 5:40 am ET · Last extended-hours $21.35 0.00%
Open$21.57
Prev close$21.27
Day range$19.83 – $22.02
Volume889.0K
Market cap$1.92B
P/E (TTM)–
Dividend yield–

BRVE Stock News

Headlines matching Braveheart Bio or the BRVE ticker, most recent first.

  • Goldman Sachs Remains a Buy on Braveheart Bio, Inc. (BRVE)TipRanks · 9 Sep 2026
  • Goldman Sachs Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $48Market news · 9 Sep 2026
  • Analysts Offer Insights on NA Companies: IMAX (IMAX) and Braveheart Bio, Inc. (BRVE)TipRanks · 9 Sep 2026
  • Analysts Offer Insights on NA Companies: Braveheart Bio, Inc. (BRVE) and TeraWulf Inc (WULF)TipRanks · 7 Sep 2026
  • A Quick Look at Today's Ratings for Braveheart Bio(BRVE.US), With a Forecast Between $40 to $48Market news · 1 Sep 2026
  • Stifel Nicolaus Remains a Buy on Braveheart Bio, Inc. (BRVE)TipRanks · 1 Oct 2026
  • Stifel Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $45Market news · 1 Oct 2026

Discussion

No comments yet — be the first to weigh in on BRVE.

Leave a comment

Scroll to Top